Bufarenogin

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H32O6
Molecular Weight	416.5073
Optical Activity	UNSPECIFIED
Defined Stereocenters	9 / 9
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@]12[C@H](CC[C@]1(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C(=O)[C@H]2O)C5=COC(=O)C=C5

InChI

InChIKey=SOGONHOGEFLVPE-PUVOGLICSA-N

InChI=1S/C24H32O6/c1-22-9-7-15(25)11-14(22)4-5-17-19(22)20(27)21(28)23(2)16(8-10-24(17,23)29)13-3-6-18(26)30-12-13/h3,6,12,14-17,19,21,25,28-29H,4-5,7-11H2,1-2H3/t14-,15+,16-,17-,19-,21-,22+,23+,24+/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

(3?,5?,12?)-3,12,14-Trihydroxy-11-oxobufa-20,22-dienolide

Preferred Name

English

Bufarenogin

Common Name

English

Bufarenogen

Common Name

English

Bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-, (3?,5?,12?)-

Common Name

English

5?-Bufa-20,22-dienolide, 3?,12?,14-trihydroxy-11-oxo-

Common Name

English

5-((3S,5R,8R,9S,10S,12S,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one

Systematic Name

English

Code System Code Type Description

FDA UNII

NX9GTE2C2W

Created by admin on Wed Apr 02 08:40:07 GMT 2025 , Edited by admin on Wed Apr 02 08:40:07 GMT 2025

PRIMARY

CAS

17008-65-0

Created by admin on Wed Apr 02 08:40:07 GMT 2025 , Edited by admin on Wed Apr 02 08:40:07 GMT 2025

PRIMARY

PUBCHEM

167607

Created by admin on Wed Apr 02 08:40:07 GMT 2025 , Edited by admin on Wed Apr 02 08:40:07 GMT 2025

PRIMARY

EPA CompTox

DTXSID10937732

Created by admin on Wed Apr 02 08:40:07 GMT 2025 , Edited by admin on Wed Apr 02 08:40:07 GMT 2025

PRIMARY

SUBSTANCE RECORD


					NX9GTE2C2W

Bufarenogin